High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia

Dysregulation of ID proteins is a frequent event in various human cancers and has a direct role in cancer initiation, maintenance, progression and drug resistance. Our previous study has revealed ID1 expression and its prognostic value in acute myeloid leukemia (AML). Herein, we further reported ID2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jing-Dong, Ma, Ji-Chun, Zhang, Ting-Juan, Li, Xi-Xi, Zhang, Wei, Wu, De-Hong, Wen, Xiang-Mei, Xu, Zi-Jun, Lin, Jiang, Qian, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696157/
https://www.ncbi.nlm.nih.gov/pubmed/29190891
http://dx.doi.org/10.18632/oncotarget.20559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696157/
https://www.ncbi.nlm.nih.gov/pubmed/29190891
http://dx.doi.org/10.18632/oncotarget.20559

Ejemplares similares